Showing results (471-480 of 515) with videos related to

Sort By:
Pageof 52
Journal of Pain and Symptom Management|January 8, 2017
Implementation and Impact of Patient Lay Navigator-Led Advance Care Planning ConversationsGabrielle B Rocque, J Nicholas Dionne-Odom, Chao-Hui Sylvia Huang, et al.
Nature Communications|July 15, 2020
Rab27a co-ordinates actin-dependent transport by controlling organelle-associated motors and track assembly proteinsNoura Alzahofi, Tobias Welz, Christopher L Robinson, et al.
CNS Drug Reviews|June 5, 2004
ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disordersLynne E Rueter, David J Anderson, Clark A Briggs, et al.
Diabetologia|May 22, 2013
Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programmeH C Looker, S O Nyangoma, D T Cromie, et al.
European Journal of Medical Genetics|July 25, 2015
Oculo-auriculo-vertebral spectrum: clinical and molecular analysis of 51 patientsAna Beleza-Meireles, Rachel Hart, Jill Clayton-Smith, et al.
Physiological Genomics|February 3, 2005
Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American populationMohammed S Orloff, Sudha K Iyengar, Cheryl A Winkler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 28, 2007
Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathwaysRobert S Bitner, William H Bunnelle, David J Anderson, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 28, 2010
In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107John Malysz, David J Anderson, Jens H Grønlien, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 2005
Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonistsMahmood Ahmed, Michael A Briggs, Steven M Bromidge, et al.
Cytokine|May 4, 2021
Differential levels of IFNα subtypes in autoimmunity and viral infectionVincent Bondet, Mathieu P Rodero, Céline Posseme, et al.
Pageof 52